Your prescription can cost more with insurance than without it, and you’re not imagining things. Researchers at the USC Schaeffer Center found that nearly 1 in 4 pharmacy claims involved patients overpaying through their insurance copay compared to the actual cost of the drug. This happens because of how insurance companies, pharmacy benefit managers, and pharmacies negotiate prices behind the scenes, creating a system where the amount you owe at the counter doesn’t always reflect what the drug actually costs.
How Copay Clawbacks Work
The most direct reason your insured price can exceed the cash price is a mechanism called a “clawback.” Here’s how it works: your insurance plan sets a fixed copay for a drug, say $15. But the pharmacy’s actual cost for that drug, plus its markup and dispensing fee, might only be $4. The pharmacy collects your full $15 copay, then the pharmacy benefit manager (PBM) that processes the claim keeps the difference. You paid $11 more than the drug cost anyone in the supply chain.
PBMs are the intermediaries that negotiate drug prices between insurance plans and pharmacies. They set the reimbursement rates pharmacies receive and determine what copay you owe. When your copay exceeds the negotiated reimbursement, the PBM pockets the surplus. An analysis of nearly 9.5 million claims found that about 2.2 million of them, roughly 23%, involved this kind of overpayment. For inexpensive generics especially, your flat copay can easily exceed the total cost of the medication.
Your Deductible Changes the Math
If you have a high-deductible health plan, the math gets even worse during the first months of the year. These plans require you to pay the full cost of most services, including prescriptions, until you hit your annual deductible. But the price you pay isn’t the pharmacy’s cash price. It’s the insurance-negotiated rate, which can be higher or lower than the cash price depending on the drug.
For common generics, discount programs like GoodRx often negotiate prices well below what your insurance plan’s contracted rate would be. So until your deductible is met, you’re paying a price that was negotiated for the insurance company’s benefit, not yours, and it may be inflated compared to what an uninsured customer would pay using a discount card. Once you clear the deductible and your plan starts covering a share, the economics can shift in your favor. But for many people filling inexpensive prescriptions, that crossover point never arrives.
Drug Tiers and Formulary Placement
Insurance plans organize covered drugs into tiers, each with a different cost-sharing level. The lowest tier, mostly generics, carries the smallest copay. Preferred brand-name drugs sit on the next tier with a higher copay, followed by non-preferred brands, and finally specialty drugs at the top with the highest out-of-pocket cost.
Where your drug lands on this list has nothing to do with its retail price and everything to do with the deals your PBM negotiated with manufacturers. A brand-name drug might be placed on a higher, more expensive tier even when the manufacturer offers it at a competitive price, simply because a competing drug’s manufacturer offered the PBM a larger rebate. You end up paying more at the pharmacy because of a financial arrangement you never see. If your medication sits on a non-preferred tier, your copay or coinsurance percentage can be substantially higher than the drug’s actual cost, especially for generics that happen to be classified in an unfavorable tier.
Cash Price vs. Insurance Price
The “usual and customary” price, or U&C, is what a pharmacy charges a customer paying entirely out of pocket without insurance or a discount card. This is often the sticker price, and it’s not always a bargain either. But discount card programs work differently. When you use a card like GoodRx, a PBM has negotiated a separate, often much lower price on behalf of that discount program. This negotiated discount price can undercut both the pharmacy’s cash price and your insurance copay.
So there are really three prices floating around for any given drug: the pharmacy’s cash price, your insurance copay or coinsurance amount, and the discount card price. For expensive brand-name drugs, insurance almost always wins. For cheap generics, the discount card price frequently beats your copay by a wide margin. The frustrating part is that you’re rarely shown all three options side by side.
Pharmacists Couldn’t Always Tell You
Until recently, many pharmacists were contractually prohibited from telling you when paying cash would be cheaper than using your insurance. These “gag clauses” in PBM contracts prevented pharmacists from volunteering that information, even when they could see the price difference on their screen.
In 2018, Congress passed the Patient Right to Know Drug Prices Act, which bars health plans and PBMs from restricting pharmacies from informing you about the price difference between your insured cost and the cash price. Many states passed similar laws around the same time. So pharmacists can now tell you, but they still may not proactively bring it up unless you ask. It’s worth asking every time you fill a prescription: “Is this cheaper if I pay without insurance?”
The Trade-Off of Paying Cash
Paying cash or using a discount card has a real downside: those payments typically don’t count toward your insurance deductible or annual out-of-pocket maximum. If you’re someone who takes multiple medications or expects significant medical expenses during the year, paying cash on cheaper prescriptions could slow your progress toward the deductible threshold where your insurance starts picking up a larger share of all your costs.
This creates a calculation you need to make each year. If you’re unlikely to hit your deductible anyway, paying cash for inexpensive generics saves money with no real penalty. If you’re on several medications and routinely hit your deductible by midyear, running those prescriptions through insurance, even at a temporarily higher price, may pay off in the long run by getting you to catastrophic coverage faster. For Medicare Part D enrollees, there’s a hard out-of-pocket cap ($2,100 in 2026) after which you pay nothing for covered drugs for the rest of the year, making deductible accumulation especially valuable for people on expensive medications.
Manufacturer Coupons and Who Can Use Them
Drug manufacturers often offer copay cards or coupons that reduce what you pay for brand-name medications, sometimes to $0. These can make an expensive drug affordable, but they come with a significant restriction: if you’re on Medicare, Medicaid, or any other federal health program, you cannot legally use them. Federal anti-kickback laws treat manufacturer coupons as an inducement to choose more expensive drugs over cheaper alternatives, which would drive up costs for government programs.
For people with commercial insurance, manufacturer coupons can be a useful tool, but they also mask the true cost of a drug. The coupon may reduce your copay today while the full price still gets billed to your plan, potentially contributing to higher premiums for everyone down the line. And coupons often expire or change terms, leaving you with the full cost once the promotional period ends.
How to Check if You’re Overpaying
Before filling any prescription, compare prices in three ways: your insurance copay (visible on your plan’s pharmacy tool or by asking the pharmacist), the pharmacy’s cash price, and the price through a discount card program. Many pharmacies will run a prescription through different pricing options if you ask.
For generics you take regularly, discount cards frequently offer prices between $3 and $15, which can undercut insurance copays of $10 to $25. For brand-name drugs, insurance is almost always cheaper because the plan’s negotiated rate accounts for manufacturer rebates you’d never get on your own. The key habit is simply asking the pharmacist to compare before you pay, a right that federal law now protects.